Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolam.

Hohmann, N; Halama, B; Siller, N; Mikus, G; Haefeli, W E

Hohmann, N; Halama, B; Siller, N; Mikus, G; Haefeli, W E.

Affiliation

Hohmann N; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Halama B; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Siller N; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.

Clin Pharmacol Ther ; 95(5): 490-1, 2014 May.

Article de En | MEDLINE | ID: mdl-24503628

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Midazolam / Cytochrome P-450 CYP3A / Kétoconazole Limites: Female / Humans / Male Langue: En Journal: Clin Pharmacol Ther Année: 2014 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google